Companies focused on psychedelic drugs traded higher on Thursday after Mind Medicine (NASDAQ:MNMD) said that the U.S. FDA issued breakthrough therapy designation for its LSD formulation, MM120 ...
We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) stands against the other ...
Enthusiasm for the psychedelic treatment of various mental health disorders, including depression and anxiety, has taken a hit with the FDA’s recent rejection of an MDMA-based therapy for PTSD. This ...
Hosted on MSN
Mind Medicine upgraded at Oppenheimer on lead asset
Shares of Mind Medicine (NASDAQ:MNMD) rallied on Monday after Oppenheimer upgraded the psychedelic drug developer to Outperform, citing the potential of its lead candidate MM120, an optimized form of ...
Mind Medicine (MNMD) has released an update. Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score ...
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) is among the Best Get Rich Fast Stocks to Buy Right Now. According to TheFly, JonesTrading initiated coverage on Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) ...
The Food And Drug Administration has granted MindMed’s LSD treatment for generalized anxiety disorder a “breakthrough therapy” status. With new robust 12-week treatment durability data, financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results